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Abstract Healthcare costs for low back pain (LBP) are
increasing rapidly. Hence, it is important to provide treat-
ments that are effective and cost-effective. The purpose of
this systematic review was to investigate the cost-effec-
tiveness of guideline-endorsed treatments for LBP. We
searched nine clinical and economic electronic databases
and the reference list of relevant systematic reviews and
included studies for eligible studies. Economic evaluations
conducted alongside randomised controlled trials investi-
gating treatments for LBP endorsed by the guideline of the
American College of Physicians and the American Pain
Society were included. Two independent reviewers
screened search results and extracted data. Data extracted
included the type and perspective of the economic evalu-
ation, the treatment comparators, and the relative cost-
effectiveness of the treatment comparators. Twenty-six
studies were included. Most studies found that interdisci-
plinary rehabilitation, exercise, acupuncture, spinal
manipulation or cognitive-behavioural therapy were cost-
effective in people with sub-acute or chronic LBP. Mas-
sage alone was unlikely to be cost-effective. There were
inconsistent results on the cost-effectiveness of advice,
insufﬁcient evidence on spinal manipulation for people
with acute LBP, and no evidence on the cost-effectiveness
of medications, yoga or relaxation. This review found
evidence supporting the cost-effectiveness of the guideline-
endorsed treatments of interdisciplinary rehabilitation,
exercise, acupuncture, spinal manipulation and cognitive-
behavioural therapy for sub-acute or chronic LBP. There is
little or inconsistent evidence for other treatments endorsed
in the guideline.
Keywords Low back pain  Cost-effectiveness analysis 
Systematic review
Introduction
Low back pain (LBP) is a common health condition which
affects most adults at some point during their lifetime [1].
For most patients in primary care, the source of symptoms
cannot be speciﬁed and the patient receives the label non-
speciﬁc LBP [2]. The exceptions are those with back pain
associated with radiculopathy or spinal stenosis [3] and the
rare patients whose LBP can be attributed to a disease or
condition such as fracture, tumour or infection [4].
Recently, the American College of Physicians and the
American Pain Society published a joint clinical guideline
which recommended the following treatments for non-
speciﬁc LBP [3]:
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advise to remain active, provide information about
effective self-care options (referred to as advice for the
rest of the paper)
• In addition, consider the use of medications with
proven beneﬁts
• For patients who do not improve, consider the addition
of spinal manipulation for acute LBP
• For patients who do not improve, consider the addition
of interdisciplinary rehabilitation, exercise, acupunc-
ture, massage, spinal manipulation, yoga, cognitive-
behavioural therapy or relaxation for sub-acute or
chronic LBP
These recommendations are largely in line with other
international guidelines [5] and are derived from the vast
amount of research regarding the effectiveness of treat-
ments for LBP. For example, the latest issue of The
Cochrane Library contains over 30 Cochrane systematic
reviews of interventions for LBP [6]. In contrast, until the
2009 British guideline [7], LBP guidelines contained little
information on the cost-effectiveness of treatments. This
was probably due to the low number of studies available to
the developers of the early guidelines. The low number of
available studies, together with methodological limitations
of the studies and the heterogeneity of the studies, limited
any conclusive evidence regarding the cost-effectiveness of
interventions for LBP [8, 9].
LBP incurs substantial treatment and loss of producti-
vity costs internationally [10]. In the United States,
healthcare costs among people with back pain increased by
65% from 1997 to 2005, more rapidly than healthcare costs
among people without back pain and the overall healthcare
costs [11]. Given that the guidelines considered a range of
interventions to be effective, the efﬁciency of treatment
will be improved if their relative cost-effectiveness is also
considered. As the number of published economic evalu-
ations of interventions for LBP is increasing, it may now be
possible to consider evidence of cost-effectiveness when
making recommendations about treatment. The purpose of
this paper is to investigate the cost-effectiveness of
guideline-endorsed treatments for non-speciﬁc LBP.
Methods
Data sources and searches
We conducted a systematic search for economic evalua-
tions (i.e. cost-minimization, cost-effectiveness, cost-utili-
zation or cost-beneﬁt analysis) [12] conducted alongside
randomised controlled trials in adults with non-speciﬁc
LBP. Treatments endorsed in the clinical practice guideline
of the American College of Physicians and the American
Pain Society were eligible for inclusion (i.e. advice, medi-
cation, spinal manipulation for acute LBP, and interdisci-
plinary rehabilitation, exercise, acupuncture, massage,
spinal manipulation, yoga, cognitive-behavioural therapy
or relaxation for sub-acute or chronic LBP) [3], except
when these treatments were implemented after spinal sur-
gery. To be included, studies had to relate the costs of the
interventions to the effects of the interventions, for exam-
ple by reporting an incremental cost-effectiveness ratio
(ICER). There was no language restriction.
We searched six clinical (Medline, EMBASE, CINAHL,
Cochrane Central Register of Controlled Trials, PsychI-
NFO and PEDro) and three economic (EconLit, NHS EED
and EURONHEED) databases from inception to 1 June
2010. The reference list of relevant systematic reviews and
included studies was also searched. Search terms were
derived from the search strategies of the Cochrane Back
Review Group (http://www.cochrane.iwh.on.ca/pdfs/CBRG_
searchstrat_Sept08.pdf) and the British National Health
Services Economic Evaluation Database (NHS EED) (http://
www.york.ac.uk/inst/crd/nhseedfaq02.htm). As an example,
the complete search strategy for EMBASE is in Appendix.
Study selection and quality assessment
Each review process (screening, risk of bias assessment
and data extraction) was conducted by two independent
reviewers, with differences resolved ﬁrst in discussion, and
then (if necessary) by arbitration by a third, independent
reviewer. In selecting eligible studies from the search
results, ﬁrst the titles, then abstracts (if available), and then
full papers were screened. For the included studies, we
used the criteria from the Cochrane Back Review Group
[13, 14] to assess the risk of bias of the trial design, and the
Consensus on Health Economic Criteria (CHEC-list) [15]
to assess the methodological quality of the economic
evaluation. Studies that scored 6 or more out of a total of
11 on the risk of bias assessment were considered as having
a low risk of bias [16]. All publications related to the
included studies (e.g. published protocol or clinical out-
comes paper) were used to inform the risk of bias assess-
ment and data extraction (see Appendix).
Data extraction, synthesis and analysis
Data were extracted using a customized data extraction
sheet, and included: the type and perspective of the eco-
nomic evaluation, treatment comparators, year/s, country
and currency of the study, and results of the relative cost-
effectiveness of the treatment comparators, which was the
primary outcome of interest. As we could not locate an
agreed cost-effectiveness threshold for the United States,
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National Institute for Health and Clinical Excellence
(NICE) as an indicator for cost-effectiveness [17]. That is,
if a treatment had an ICER lower than £20,000–£30,000
per quality-adjusted life-years (QALY) gained, the treat-
ment was deemed as relatively cost-effective compared to
an alternate treatment. Where a treatment incurred signi-
ﬁcantly lower costs and was statistically signiﬁcantly more
effective compared to an alternate treatment, the treatment
was considered as ‘‘dominant’’.
Results
Characteristics of included trials
A total of 26 studies were included after screening the 1961
records found in the search (Fig. 1). Results of two separate
studies [18, 19] were reported in one paper [20]. These
studies had almost identical design features so are referred
to as ‘‘Strong et al.’’ in the current paper. For two of the
included studies, results of the one- and two-year follow-up
were published separately [21–24]. Most studies conducted
a cost-effectiveness and/or cost-utility analysis. One study
conducted a cost-effectiveness analysis as well as a cost-
beneﬁt analysis [25]. Four other studies conducted a
cost-beneﬁt analysis [26–29] and two studies conducted a
cost-minimization analysis [30, 31]. One study did not
clearly state the type of economic evaluation undertaken,
but we consider this to be a cost-effectiveness analysis due
to the outcomes reported [21, 22].
Most studies recruited participants with at least
4–6 weeks (sub-acute) or greater than 12 weeks (chronic)
of LBP. The only exceptions were two studies which
recruited participants of a mixed duration of symptoms [30,
32] two which did not specify the duration of symptoms
[20], and one which recruited participants sick listed for
less than 2 weeks due to LBP [31]. Most studies were
conducted in the UK [32–40] or other European countries
[21–24, 26–29, 31, 41–45]; three studies were conducted in
the United States [20, 30] and two in Canada [25, 46]. All
studies were published in English.
Records identified through 
database searching 
(n = 2945)  
Additional records identified 
through other sources 
(n = 3)
Records after duplicates removed
(n = 1961) 
Records screened
(n = 1961) 
Records excluded
(n = 1862) 
Full-text articles assessed 
for eligibility 
(n = 99)
Full-text articles excluded
(n = 72) 
 
￿  35 not full economic 
evaluation 
￿  13 not randomised 
controlled trials 
￿  13 not non-specific 
low back pain 
￿  7 did not include 
guideline-endorsed 
treatments 
￿ 4  repeated 
publications 
Studies included
(n = 26) 
Fig. 1 Flow of study
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123Risk of bias of the trial design
Just over half (n = 13) of the studies had a low risk of bias.
Five of the studies did not report adequate randomization
procedures [19, 20, 40, 41], nine did not have adequate
allocation concealment [18–20, 23, 24, 29, 31, 39, 41, 44,
46] and none of the studies used assessor blinding
(Table 1).
Quality of the economic evaluation
Eleven studies scored 17 or more out of 19 on the CHEC-
list. Seven studies did not state the economic perspective
adopted [21, 22, 29–32, 35, 41]. An incremental cost-
effectiveness analysis was conducted in all but 2 of the 19
cost-effectiveness or cost-utility studies [23, 24, 41]. Three
of the nine studies which had a follow-up period of greater
than 1 year did not use discounting [23–25, 30]. Other
methodological issues are outlined in the following sec-
tions describing the evidence for each treatment (Table 1).
Advice (provide evidence-based information
on prognosis, advise to remain active, provide
information about effective self-care options)
A total of nine studies were included (Table 2). Six studies
compared advice to another treatment [20–22, 27, 38, 46],
and three compared adding another treatment to advice
with advice alone [23, 24, 26, 36]. Regardless of the
comparison and the economic perspective adopted, results
regarding the cost-effectiveness of advice were inconsis-
tent across the studies (Table 2). Four studies suggested
that advice may be more cost-effective than treatments
received in primary care [21, 22, 27] or a book on back
pain care [20], but other studies reported a cost-effective-
ness ratio or cost-beneﬁt outcome which favoured adding
naturopathic care [46], graded activity [26],or manipulation
and stabilizing exercises [23, 24] over advice alone, or
physiotherapy over advice [38]. In a study comparing
adding manipulation and exercises to advice alone [23, 24],
it is unclear why the reported cost-effectiveness ratio was
positive for pain but negative for disability, given that costs
were identical and the direction of beneﬁts was the same
for both outcomes.
There were methodological issues regarding the identi-
ﬁcation and measurement of costs in ﬁve of the eight
studies. One study [46] undertook their analysis from the
societal perspective, but did not collect the costs of visits to
doctors, or secondary or tertiary care. It was unclear why
some of the costs reported had a negative value, and their
follow-up period (6 months) may be too short to fully
capture the economic consequences of sub-acute or chronic
LBP. Two studies [20] undertook their analysis from the
health insurer’s perspective but excluded the costs of
inpatient care. Both studies which conducted a cost-beneﬁt
analysis [26, 27] had a 3-year follow-up, but collected only
the costs incurred in the ﬁrst year. One of these studies did
not state the methods used to value the costs [27].
In addition, consider the use of medications
with proven beneﬁts
Nostudycomparedthe cost-effectiveness ofanymedication
in managing LBP. This included the ﬁrst-line recommen-
dation of acetaminophen and non-steroidal anti-inﬂamma-
tory drugs, more potent analgesics such as opioids or
tramadol, and herbal therapies.
Table 1 Risk of bias and methodological quality assessment using
the Cochrane Back Review Group criteria [13, 14] and the Consensus
Health Economic Criteria (CHEC-list) [15], respectively
Risk of bias
score (/11)
CHEC-list
(/19)
a
Critchley et al. [33] 7 19 (0)
Goossens et al. [41] 2 14 (1)
Herman et al. [46] 6 17 (1)
Hlobil et al. [26] 7 15 (2)
Hollinghurst et al. [34] 7 17 (1)
Johnson et al. [35] 7 12 (1)
Karjalainen et al. [21, 22] 8 13 (0)
Kominski et al. [30] 5 11 (4)
Lamb et al. [36] 7 15 (1)
Loisel et al. [25] 5 14 (0)
Molde Hagen et al. [27] 7 12 (1)
Niemisto et al. [23, 24] 6 16 (0)
Ratcliffe et al. [37] 5 19 (0)
Rivero-Arias et al. [38] 8 18 (1)
Rivero-Arias et al. [39] 5 18 (0)
Schweikert et al. [44] 5 17 (1)
Seferlis et al. [31] 4 7 (5)
Skouen et al. [28] 5 14 (1)
Smeets et al. [42] 8 18 (1)
Strong et al. [20] 4 13 (1)
Torstensen et al. [29] 6 9 (2)
UK BEAM Trial Team [40] 5 17 (1)
Van der Roer et al. [43] 6 18 (1)
Whitehurst et al. [32] 6 17 (1)
Witt et al. [45] 4 13 (1)
Studies with a risk of bias score of 6 or more were considered to have
a low risk of bias [16]
a The number of items that were not applicable from the CHEC-list is
in parentheses. For example, performing an incremental cost-effec-
tiveness analysis (item 13) was not applicable for cost-minimization
or cost-beneﬁt analysis, and discounting (item 14) was not applicable
for studies with a follow-up of 1 year or less
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123Table 2 The cost-effectiveness of ‘‘advice’’ (provide evidence-based information on prognosis, advise to remain active, provide information
about effective self-care options)
Study ID Comparative treatments Details of economic
evaluation
Results of economic evaluation
Herman et al. [46] Advice (advice and back booklet)
Naturopathic care (acupuncture,
relaxation) and back booklet
Type: CEA/CUA
Perspective: societal,
employer and patient
Setting: Canada, 2005
Follow-up: 6 months
ICER for naturopathic care compared to advice:
QALY (SF-6D) = naturopathic care and back
booklet dominant (i.e. incurred lower costs and
more effective) from societal and patient’s
perspective
Absenteeism = 154 (2005 USD) per absentee
day avoided from employer’s perspective
Hlobil et al. [26] Advice
Advice plus graded activity using
cognitive-behavioural principles
Type: CBA
Perspective: employer
Setting: The Netherlands,
1999–2000
Follow-up: 1 year for costs,
3 years for other
outcomes
Mean cost beneﬁt = 999 (1999 Euro) favouring
advice plus graded activity (95% CI -1,073
to 3,115)
Lamb et al. [36] Group cognitive behavioural
intervention plus advice
Advice
Type: CEA/CUA
Perspective: healthcare
sector
Setting: United Kingdom,
price year 2008
Follow-up: 1 year
ICER for Group cognitive behavioural intervention
plus advice = 1,786 (2008 GBP) per QALY
gained (EQ-5D)
Karjalainen et al.
[21, 22]
GP care
GP care plus advice (advice,
education, exercise)
Type and perspective: not
stated
Setting: Finland 1998–2000
Follow-up: 24 months
No ICER conducted, but advice incurred lower
costs and was more effective in proving daily
symptoms, pain bothersomeness, satisfaction,
days on sick leave (i.e. dominant).
Molde Hagen et al.
[27]
Advice (advice and simple
exercises)
Usual care in primary care
Type: CBA
Perspective: societal
Setting: Norway, price year
1995
Follow-up: 1 year for costs,
3 years for other
outcomes
Mean cost beneﬁt = 3,497 (1995 USD) favouring
advice
Niemisto et al. [23,
24]
Advice (advice, education and
simple exercises)
Advice plus manipulation and
stabilizing exercises
Type: CEA/CUA
Perspective: societal
Setting: Finland, study
initiated in 1999
Follow-up: 2 years
ICER for advice plus manipulation and stabilizing
exercises compared to advice [mean (95% CI)]:
Pain = 512 (2002 USD) per 1 point gained on a
100-point scale (77–949)
Disability (Oswestry) =- 78 (2002 USD) per 1
point gained on a 100-point scale (-655 to 499)
Rivero-Arias et al.
[38]
Advice
Physiotherapy
Type: CEA/CUA
Perspective: unspeciﬁed for
ICER
Setting: United Kingdom,
1997–2001
Follow-up: 1 year
ICER for physiotherapy compared to advice:
3,010 (2004 GBP) per QALY gained (EQ-5D)
Strong et al. [20] for
Moore et al. [18]
Book on back pain care
Advice (psychologist-led group
education sessions)
Type: CEA/CUA
Perspective: health insurer
Setting: United States,
1996–1997
Follow-up: 1 year
ICER for advice compared to book
[mean (95% CI)]:
6.13 (USD, price year not reported) per one
low-impact back pain days (1.48–21.14)
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of spinal manipulation for acute LBP
Only one study investigated the cost-effectiveness of spinal
manipulation in people with acute LBP [31]. Results of this
cost-minimization study showed that while spinal mani-
pulation was not the cheapest treatment option, the
differences in costs over 1 year compared to care provided
by a general practitioner (GP care) or exercise appeared
small (total cost in Swedish crowns, price year not stated,
for spinal manipulation = 49,076, GP care = 50,834 and
exercise = 45,423). However, there was no formal statis-
tical comparison and this study had incomplete cost iden-
tiﬁcation (only the costs of study treatment, investigations
and operations were collected as the direct costs).
For patients who do not improve, consider the addition
of interdisciplinary rehabilitation, exercise,
acupuncture, massage, spinal manipulation, yoga,
cognitive-behavioural therapy or relaxation
for sub-acute or chronic LBP
Fifteen studies investigated the cost-effectiveness of
interdisciplinary rehabilitation, exercise, spinal manipula-
tion or cognitive-behavioural therapy. These interventions
were compared to conventional physiotherapy [29, 32,
33, 43], GP care [25, 28, 30, 35], spinal surgery [29]o r
walking [39], or as an additional treatment to advice [23,
24, 26], GP care [34, 36, 40] or inpatient rehabilitation
[44]. Regardless of the comparisons and the perspectives
adopted, all but two studies [30, 32] found that these
interventions were cost-effective compared to the treatment
alternatives (Table 3). In particular, Schweikert et al. [44]
found that adding cognitive-behavioural therapy to inpa-
tient rehabilitation dominated over inpatient rehabilitation
alone (ICER =- 126,731 in 2001 Euro per QALY
gained), and Torstensen et al. [29] found that medical
exercise therapy dominated over walking (cost bene-
ﬁt = 906,732 in Norwegian Kroner, price year not stated).
However, Schweikert et al. [44] had a follow-up of
6 months, which may be too short to adequately measure
the economic consequences of chronic LBP. Torstensen
et al. [29] did not specify the perspective of the economic
evaluation. Given that people in the walking group incurred
no costs, it is likely that this study conducted the economic
evaluation from a narrow perspective, including the costs
of the study treatment only.
Four studies compared interdisciplinary rehabilitation,
exercise, spinal manipulation and cognitive-behavioural
therapy to each other. Critchley et al. [33] found that a pain
management programme using cognitive-behavioural
principles was likely to be more cost-effective compared to
exercise from the healthcare sector’s perspective. Smeets
et al. [42] found that, from a societal perspective, the
combination of exercise with graded activity and problem
solving was not cost-effective compared to exercise or
graded activity and problem solving alone (e.g. ICER for
exercise compared to combined group = 35,060 in 2003
Euro per QALY gained, ICER for graded activity and
problem solving compared to combined group = domi-
nant). In contrast, combining both manipulation and exer-
cise with GP care was relatively cost-effective (ICER =
3,800 per QALY gained) compared to manipulation plus
GP care (ICER = 4,800 per QALY gained), or exercise
plus GP care (ICER = 8,300 per QALY gained) from the
UK healthcare sector’s perspective (in 2000–2001 GBP)
[40]. One study showed that receiving an operant condi-
tioning programme with group discussion or a cognitive
behavioural component and relaxation incurred lower
direct and indirect costs compared to waiting list then
receiving the operant conditioning programme, but did not
report an incremental cost-effectiveness analysis [41].
Witt et al. found that adding acupuncture to physician
care had a low ICER compared to physician care alone
from the societal perspective (€ 10,526 per QALY gained
in 2006 Euros, or GBP 7839.29 converted using purchasing
power parities www.oecd.org/dataoecd/61/54/18598754.
pdf)[ 45]. But this result is limited by methodological
Table 2 continued
Study ID Comparative treatments Details of economic
evaluation
Results of economic evaluation
Strong et al. [20] for
vonKorffetal.[19]
Book on back pain care
Advice (layperson-led group
education sessions)
Type: CEA/CUA
Perspective: health insurer
Setting: United States,
1996–1997
Follow-up: 1 year
ICER for advice compared to book [mean (95%
CI)]:
9.70 (USD, price year not reported) per one low-
impact back pain days (-45.45 to 78.86)
The study included other comparison groups. Only data from the speciﬁed groups were included
CBA cost-beneﬁt analysis, CEA cost-effectiveness analysis, CUA cost-utility analysis, GBP British pounds, GP care care provided by a general
practitioner or a primary care physician, ICER incremental cost-effectiveness ratio, in cost per 1 unit of effect gained, LBP low back pain, QALY
quality-adjusted life-years, USD United States dollars
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sub-acute or chronic low back pain
Study Comparative treatments Details of economic evaluation Results of economic evaluation
Critchley et al. [33] Physiotherapy
Spinal stabilization exercises
Pain management programme
using CBT
Type: CEA/CUA
Perspective: healthcare sector
Setting: United Kingdom, 2002–2005
Follow-up: 18 months
No raw data reported, but pain
management programme associated
with least costs and acceptability curve
shows that it is likely to be most cost-
effective
Hlobil et al. [26] Advice
Advice plus graded activity
using CBT
Type: CBA
Perspective: employer
Setting: The Netherlands, 1999–2000
Follow-up: 1 year for costs, 3 years
for other outcomes
Mean cost beneﬁt = 999 (1999 Euro)
favouring advice plus graded activity
(95% CI -1,073 to 3,115)
Hollinghurst et al. [34] GP care
GP care plus exercise and
behavioural counselling
Type: CEA/CUA
Perspective: healthcare sector,
patients, societal
Setting: United Kingdom 2002–2004
Follow-up: 18 months
ICER for GP care plus exercise and
behavioural counselling compared to
GP care (in 2005 GBP per 1 unit of
effect gained, from the healthcare
sector’s perspective only):
Disability (RMDQ) = 61
Pain-free days = 9
QALY gained (EQ-5D) = 2,847
Johnson et al. [35] GP care
Exercise and education using
CBT
Type: CEA/CUA
Perspective: not stated
Setting: United Kingdom 2002–2003
Follow-up: 15 months
ICER for exercise and education using
CBT compared to GP care:
5,000 (2003–2004 GBP) per QALY
gained (EQ-5D)
Kominski et al. [30] GP care
Chiropractic care
(manipulation, instruction in
back care and exercise)
Type: CMA
Perspective: not stated
Setting: United States 1995–1998
Follow-up: 18 months
Costs over 18 months in USD [price year
not stated, mean (SD)]:
GP care = 463 (1,225)
Chiropractic care = 550 (834)
GP care signiﬁcantly cheaper
Lamb et al. [36] Group cognitive behavioural
intervention plus advice
Advice
Type: CEA/CUA
Perspective: healthcare sector
Setting: United Kingdom, price year
2008
Follow-up: 1 year
ICER for Group cognitive behavioural
intervention plus advice = 1,786 (2008
GBP) per QALY gained (EQ-5D)
Loisel et al. [25] GP care
Clinical rehabilitation (back
pain specialist, back
school ± multidisciplinary
rehabilitation)
Type: CEA/CUA and CBA
Perspective: insurance provider
Setting: Canada 1991–1993
Follow-up: mean 6.4 years
ICER for treatments compared to GP care
(in 1998 Canadian dollars per 1 day on
full beneﬁt):
Clinical rehabilitation =- 67.6
dominant
Niemisto et al. [23, 24] Advice (advice, education and
simple exercises)
Advice plus manipulation and
stabilizing exercises
Type: CEA/CUA
Perspective: societal
Setting: Finland, study initiated in
1999
Follow-up: 2 years
ICER for advice plus manipulation and
stabilizing exercises compared to advice
[in 2002 USD per 1 point gained, mean
(95% CI)]:
Pain (0–100) = 512 (77–949)
Disability (Oswestry, 0–100) =- 78
(-655 to 499)
Rivero-Arias et al. [39] Outpatient rehabilitation
Spinal surgery
Type: CEA/CUA
Perspective: healthcare sector and
patient
Setting: United Kingdom, 1996–2002
Follow-up: 2 years
ICER for spinal surgery compared to
outpatient rehabilitation [in 2002–2003
GBP]:
48,588 per QALY gained
(95% CI -279,883 to 372,406)
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123issues. For example, the costs collected (provided by health
insurance funds) may be incomplete for the perspective
adopted (societal), the methods of cost valuation were
not reported, and data were collected immediately after
the treatment period with no other follow-up. Ratcliffe
et al. [37] showed that acupuncture had a low ICER
compared to GP care from the healthcare sector perspective
(4,241 in 2002 to 2003 GBP per QALY gained, 95%
CI = 191–28,026), and was dominant over GP care from
the societal perspective.
Hollinghurst et al. [34] investigated the cost-effective-
ness of massage over a 1-year period. Compared to GP care,
massage incurred higher costs from the healthcare sector’s
perspective and was less effective (QALY gained =
-34,473 in 2005 GBP). But adding exercise and behavioural
counselling to massage improved the cost-effectiveness of
Table 3 continued
Study Comparative treatments Details of economic evaluation Results of economic evaluation
Schweikert et al. [44] Inpatient rehabilitation
Inpatient rehabilitation plus
CBT
Type: CEA/CUA
Perspective: societal
Setting: Germany, price year 2001
Follow-up: 6 months
ICER for inpatient rehabilitation plus
CBT compared to inpatient
rehabilitation
-126,731 (2001 Euro) per QALY gained
(EQ-5D, dominant)
Skouen et al. [28] GP care
Light interdisciplinary
rehabilitation
Extensive interdisciplinary
rehabilitation
Type: CBA
Perspective: societal
Setting: Norway 1996–1997
Follow-up: 2 years after end of
treatment
Cost beneﬁt for treatments compared to
GP care:
Light interdisciplinary rehabilitation in
male patients = 7,240,900 (1998
Norwegian kroner) for the male
participants (n = 21) over 24 months
Extensive interdisciplinary rehabilitation
—no data reported
Torstensen et al. [29] Medical exercise therapy
Physiotherapy
Walking
Type: CBA
Perspective: not reported
Setting: Norway, 1993–1996
Follow-up: 15 months
Cost beneﬁt compared to walking in
Norwegian Kroner (price year not
reported):
Medical exercise therapy
(n = 69) = 906,732 less
Physiotherapy (n = 67) = 1,882,560
less
UK BEAM Trial Team
[40]
GP care
GP care plus exercise
GP care plus manipulation
GP care plus manipulation
followed by exercise
Type: CEA/CUA
Perspective: healthcare sector
Setting: United Kingdom, 1999–2002
Follow-up: 1 year
ICER for treatments compared to GP care
[in 2000–2001 GBP per QALY gained
(EQ-5D)]:
GP care plus exercise = 8,300
GP care plus manipulation = 4,800
GP care plus manipulation followed by
exercise = 3,800
Van der Roer et al. [43] Exercise and back school
(using behavioural
principles)
Physiotherapy
Type: CEA/CUA
Perspective: societal
Setting: The Netherlands, price year
2004
Follow-up: 1 year
ICER for exercise and back school
compared to physiotherapy (in 2004
Euro per unit of effect gained):
Disability (RMDQ) = 16,349
Pain (numerical rating scale) =- 175
(dominant)
Perceived effects (Global perceived
effects scale) = 1,720
QALY (EQ-5D) = 5,141
Whitehurst et al. [32] Physiotherapy
Pain management programme
using CBT
Type: CEA/CUA
Perspective: healthcare sector
Setting: United Kingdom, price years
2001–2002
Follow-up: 1 year
ICER for physiotherapy compared to pain
management (in 2001–2002 GBP per
unit of effect gained):
Disability (RMDQ) = 156
QALY (EQ-5D) = 2,362
CBA cost-beneﬁt analysis, CEA cost-effectiveness analysis, CUA cost-utility analysis, GBP British pounds, GP care care provided by a general
practitioner or a primary care physician, ICER incremental cost-effectiveness ratio, LBP low back pain, QALY quality-adjusted life-years, USD
United States dollars
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123massage (ICER compared to GP care plus exercise and
behavioural counselling = 5,304 in 2005 GBP). No studies
investigated the cost-effectiveness of yoga or relaxation.
Discussion
We found 26 economic evaluations conducted alongside
randomised controlled trials that investigated the cost-
effectiveness of guideline-endorsed treatments for non-
speciﬁc LBP. There were inconsistent ﬁndings regarding
the cost-effectiveness of advice, but studies generally
showed that interdisciplinary rehabilitation, exercise, acu-
puncture, spinal manipulation and cognitive-behavioural
therapy were relatively cost-effective for people with sub-
acute or chronic LBP. Results from single studies sug-
gested that massage alone was unlikely to be cost-effective,
and that the cost-effectiveness of spinal manipulation for
acute LBP was unclear. No studies investigated the cost-
effectiveness of medication, yoga or relaxation as treat-
ments for LBP.
The eight studies which investigated advice did not yield
consistent or conclusive evidence about its relative cost-
effectiveness. Interestingly, these studies also reported
inconsistencies in the effectiveness of advice compared to
other treatments. In contrast, the American clinical guide-
line made a strong recommendation for advice to stay
active based on moderate-quality evidence [3]. Other
guidelines also recommend advice to stay active [5]. One
reason for the difference between our ﬁndings and guide-
line recommendations may be that in the guidelines, the
recommendations were based on evidence from systematic
reviews which compared advice to stay active with bed
rest, which is considered potentially harmful for this popu-
lation [47]. The studies included in this review compared
advice to a variety of treatment alternatives, but not bed
rest.
We did not pool the results in the studies that compared
advice, and interdisciplinary rehabilitation, exercise, acu-
puncture, spinal manipulation and cognitive-behavioural
therapy for sub-acute or chronic LBP, as may occur in a
systematic review of treatment effectiveness. This is due to
the heterogeneity in study treatments, as well as differences
in economic perspectives and settings. The underlying
assumption for pooling in a systematic review of treatment
effectiveness is that results obtained in one country are
generalisable to a similar population in a different setting
or country. Whilst it seems reasonable to assume that
individuals or groups are likely to react in the same way to
a particular intervention, no matter where they live, com-
paring economic data across different settings or countries
is not as straightforward due to differences in the structure
and organization of healthcare systems. For example, in
some countries patients may have direct access to medical
specialists or other healthcare providers while in other
countries patients need a referral from a primary care
physician. Access to some care providers may be limited in
some countries where this care is not provided by a public
healthcare system or is not reimbursed by an insurance
scheme. Cost data may also be sensitive to the funding and
reimbursement arrangements in a particular healthcare
system. However, despite this complexity, there are
emerging guidelines on the transferability of economic
evaluations [48–50].
We used the NICE threshold to provide an indication of
the cost-effectiveness of treatment, because the NICE
threshold is commonly available. However, it should be
noted that there is no consensus about the maximum costs
per QALY gained that would be acceptable, and recent
evidence indicates that the cost-effectiveness threshold may
vary depending upon the severity and the prevalence of the
disease. We used the treatments endorsed by the American
College of Physicians and the American Pain Society as
guideline-endorsed treatments, because at the time of study
conception the American guideline was one of the most
recent guidelines. A recent review shows that treatments
endorsed by the American guideline are in line with other
guidelines [5]. The only area of contention is in the use of
spinal manipulation where, unlike the American guideline,
some countries do not recommend spinal manipulation for
LBP. Interestingly, our systematic review considers evi-
dence purely from a cost-effectiveness perspective and
shows some evidence of cost-effectiveness when using
spinal manipulation in sub-acute to chronic pain.
There were some methodological issues which limit the
interpretation of our ﬁndings. These include the incomplete
identiﬁcation and measurement of costs, which reduces the
rigouroftheresults.Threestudieshadfollow-upperiodsthat
are likely to be too short to fully appreciate the economic
consequences forthe chronic populationunderinvestigation
[44–46]. Based on recent large cohort studies on the prog-
nosis of acute [51] and chronic [52] LBP, we recommend a
follow-up period of at least 3 months for acute LBP and at
least12 monthsforchronicLBP.Inaddition,tohelpreaders
assesstheextenttowhichtheresultsofstudiesareapplicable
to different healthcare systems, we recommend that eco-
nomic evaluations report unit costs as well as reporting a
breakdownofcostsandresourceutilization.Elevenofthe26
includedstudiesprovidedatableofunitcosts[21,22,33,34,
37–40, 42, 43, 46, 53].
Considering the evidence regarding both relative effec-
tiveness and cost-effectiveness when making treatment
recommendations means that the endorsed treatments are
bothbeneﬁcialtopatientsandefﬁcientintermsofhealthcare
resources. The small number or lack of economic evalua-
tions for some guideline-endorsed treatments means well-
1032 Eur Spine J (2011) 20:1024–1038
123conducted economic evaluations are required to strengthen
theevidence-baseoftreatmentsforLBP.However,evidence
to date indicates that guideline-endorsed treatments such as
interdisciplinary rehabilitation, exercise, acupuncture,
spinal manipulation and cognitive-behavioural therapy for
sub-acute or chronic LBP are cost-effective. Although
advice to stay active is endorsed in the guideline, and evi-
dence regarding its cost-effectiveness compared to other
interventions is inconsistent. In addition, there is little or no
high-level evidence about other guideline-endorsed treat-
ments: medication, spinal manipulation for acute LBP, and
massage, yoga or relaxation for chronic LBP.
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Appendix: Search strategy for Embase (via OvidSP)
Part A: Generic search for randomized controlled trials and
controlled clinical trials
1 Clinical Article/
2 exp Clinical Study/
3 Clinical Trial/
4 Controlled Study/
5 Randomized Controlled Trial/
6 Major Clinical Study/
7 Double Blind Procedure/
8 Multicenter Study/
9 Single Blind Procedure/
10 Phase 3 Clinical Trial/
11 Phase 4 Clinical Trial/
12 crossover procedure/
13 placebo/
14 or/1-13
15 allocat$.mp.
16 assign$.mp.
17 blind$.mp.
18 (clinic$ adj25 (study or trial)).mp.
19 compar$.mp.
20 control$.mp.
21 cross?over.mp.
22 factorial$.mp.
Appendix continued
23 follow?up.mp.
24 placebo$.mp.
25 prospectiv$.mp.
26 random$.mp.
27 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or
mask$)).mp.
28 trial.mp.
29 (versus or vs).mp.
30 or/15-29
31 14 and 30
32 human/
33 Nonhuman/
34 exp ANIMAL/
35 Animal Experiment/
36 33 or 34 or 35
37 32 not 36
38 31 not 36
39 37 and 38
40 38 or 39
Part B: Speciﬁc search for low back problems
41 dorsalgia.mp.
42 back pain.mp.
43 exp LOW BACK PAIN/
44 exp BACKACHE/
45 (lumbar adj pain).mp.
46 lumbago.mp.
47 or/41-46
Part C: Speciﬁc search for economic evaluation
48 health-economics/
49 exp economic-evaluation/
50 exp health-care-cost/
51 exp pharmacoeconomics/
52 OR\48-51
53 (econom$ or cost or costs or costly or costing or price or prices or
pricing or pharmacoeconomic$).ti,ab
54 (expenditure$ not energy).ti,ab
55 (value adj2 money).ti,ab
56 budget$.ti,ab
57 OR\53-56
58 52 or 57
59 (metabolic adj cost).ti,ab
60 ((energy or oxygen) adj cost).ti,ab
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61 ((energy or oxygen) near expenditure).ti,ab
62 OR\59-61
63 58 not 62
Part D: combine
64 40 AND 47 AND 63
Included studies Related publications used
• Critchley DJ, Ratcliffe J,
Noonan S, Jones RH, Hurley
MV (2007) Effectiveness and
cost-effectiveness of three types
of physiotherapy used to reduce
chronic low back pain
disability: a pragmatic
randomized trial with economic
evaluation. Spine
32(14):1474–1481
Nil
• Goossens ME, Rutten-Van
Molken MP, Kole-Snijders AM,
Vlaeyen JW, Van Breukelen G,
Leidl R (1998) Health economic
assessment of behavioural
rehabilitation in chronic low
back pain: a randomised clinical
trial. Health Econ 7(1):39–51
Nil
• Herman PM, Szczurko O,
Cooley K, Mills EJ (2008) Cost-
effectiveness of naturopathic
care for chronic low back pain.
Altern Ther Health Med
14(2):32–39
• Szczurko O, Cooley K, Busse
JW, Seely D, Bernhardt B,
Guyatt GH, et al (2007)
Naturopathic care for chronic
low back pain: a randomized
trial. PLoS One 2:e919
• Hlobil H, Uegaki K, Staal JB,
de Bruyne MC, Smid T, van
Mechelen W (2007) Substantial
sick-leave costs savings due to a
graded activity intervention for
workers with non-speciﬁc sub-
acute low back pain. Eur Spine
J 16(7):919–924
• Staal JB, Hlobil H, Twisk JW,
Smid T, Ko ¨ke AJ, van
Mechelen W (2004) Graded
activity for low back pain in
occupational health care: a
randomized, controlled trial.
Ann Intern Med 140:77–84
• Hollinghurst S, Sharp D,
Ballard K, Barnett J, Beattie A,
Evans M, Lewith G, Middleton
K, Oxford F, Webley F, Little P
(2008) Randomised controlled
trial of alexander technique
lessons, exercise, and massage
(ateam) for chronic and
recurrent back pain: economic
evaluation. BMJ 337:a2656
• Little P, Lewith G, Webley F,
Evans M, Beattie A, Middleton
K, et al (2008) Randomised
controlled trial of Alexander
technique lessons, exercise, and
massage (ATEAM) for chronic
and recurrent back pain. BMJ
337:a884
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• Johnson RE, Jones GT, Wiles
NJ, Chaddock C, Potter RG,
Roberts C, Symmons DPM,
Watson PJ, Torgerson DJ,
Macfarlane GJ (2007) Active
exercise, education, and
cognitive behavioral therapy for
persistent disabling low back
pain: a randomized controlled
trial. Spine 32(15):1578–1585
Nil
• Karjalainen K, Malmivaara A,
Mutanen P, Roine R, Hurri H,
Pohjolainen T (2004) Mini-
intervention for subacute low
back pain: two-year follow-up
and modiﬁers of effectiveness.
Spine 29(10):1069–1076
• Karjalainen K, Malmivaara A,
Pohjolainen T, Hurri H,
Mutanen P, Rissanen P,
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H, Roine R (2003) Mini-
intervention for subacute low
back pain: a randomized
controlled trial. Spine
28(6):533–540
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• Kominski GF, Heslin KC,
Morgenstern H, Hurwitz EL,
Harber PI (2005) Economic
evaluation of four treatments for
low-back pain: results from a
randomized controlled trial.
Med Care 43(5):428–435
• Hurwitz EL, Morgenstern H,
Harber P, Kominski GF, Belin
TR, Yu F, et al (2002) A
randomized trial of medical care
with and without physical
therapy and chiropractic care
with and without physical
modalities for patients with low
back pain: 6-month follow-up
outcomes from the UCLA low
back pain study. Spine
27:2193–2204
• Lamb SE, Hansen Z, Lall R,
Castelnuovo E, Withers EJ,
Nichols V, Potter R,
Underwood MR (2010) Group
cognitive behavioural treatment
for low-back pain in primary
care: a randomised controlled
trial and cost-effectiveness
analysis. Lancet
375(9718):916–923
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• Loisel P, Lemaire J, Poitras S,
Durand MJ, Champagne F,
Stock S, Diallo B, Tremblay C
(2002) Cost-beneﬁt and cost-
effectiveness analysis of a
disability prevention model for
back pain management: a six
year follow up study. Occup
Environ Med 59(12):807–815
• Loisel P, Abenhaim L, Durand
P, Esdaile JM, Suissa S,
Gosselin L, et al (1997) A
population-based, randomized
clinical trial on back pain
management. Spine
22:2911–2918
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• Molde Hagen E, Grasdal A,
Eriksen HR (2003) Does early
intervention with a light
mobilization program reduce
long-term sick leave for low
back pain: a 3-year follow-up
study. Spine 28(20):2309–2315
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• Niemisto L, Lahtinen-Suopanki
T, Rissanen P, Lindgren K-A,
Sarna S, Hurri H (2003) A
randomized trial of combined
manipulation, stabilizing
exercises, and physician
consultation compared to
physician consultation alone for
chronic low back pain. Spine
28(19):2185–2191
• Niemisto L, Rissanen P, Sarna
S, Lahtinen-Suopanki T,
Lindgren K-A, Hurri H (2005)
Cost-effectiveness of combined
manipulation, stabilizing
exercises, and physician
consultation compared to
physician consultation alone for
chronic low back pain: a
prospective randomized trial
with 2-year follow-up. Spine
30(10):1109–1115
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• Ratcliffe J, Thomas KJ,
MacPherson H, Brazier J (2006)
A randomised controlled trial of
acupuncture care for persistent
low back pain: cost
effectiveness analysis. BMJ
333(7569):626
• Thomas KJ, MacPherson H,
Ratcliffe J, Thorpe L, Brazier J,
Campbell M, et al (2005)
Longer term clinical and
economic beneﬁts of offering
acupuncture care to patients
with chronic low back pain.
Health Technol Assess 9:iii–iv,
ix–x, 1-109
• Rivero-Arias O, Gray A, Frost
H, Lamb SE, Stewart-Brown S
(2006) Cost-utility analysis of
physiotherapy treatment
compared with physiotherapy
advice in low back pain. Spine
31(12):1381–1387
• Frost H, Lamb SE, Doll HA,
Carver PT, Stewart-Brown S
(2004) Randomised controlled
trial of physiotherapy compared
with advice for low back pain.
BMJ 329:708
• Rivero-Arias O, Campbell H,
Gray A, Fairbank J, Frost H,
Wilson-MacDonald J (2005)
Surgical stabilisation of the
spine compared with a
programme of intensive
rehabilitation for the
management of patients with
chronic low back pain: cost
utility analysis based on a
randomised controlled trial.
BMJ 330(7502):1239
• Fairbank J, Frost H, Wilson-
MacDonald J, Yu LM, Barker
K, Collins R, et al (2005)
Randomised controlled trial to
compare surgical stabilisation
of the lumbar spine with an
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programme for patients with
chronic low back pain: the
MRC spine stabilisation trial.
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analysis of three conservative
treatment programmes in 180
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Conservative treatment in
patients sick-listed for acute
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7:461–470
• Skouen JS, Grasdal AL,
Haldorsen EMH, Ursin H
(2002) Relative cost-
effectiveness of extensive and
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